Martin-Luther-Universität Halle-Wittenberg

Halle 06120

1 studies enrolling now · 6 studies all time

What they study most

Bronchiectasis, GVHD, HNSCC, Hypopharynx Cancer, Larynx Cancer, Leukemia, Myeloid, Acute, Metastatic gpNMB Over-expressing Triple Negative Breast Cancer, Neoplasms, Oral Cavity Cancer, Oropharynx Cancer

Studies at this site

• The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis — Recruiting now
• Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy — Recruiting now
• A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer — Running, not enrolling
• Proof-of-concept Trial of Apraglutide in Acute Graft Versus Host Disease (aGVHD) — Stopped early
• Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2) — Completed
• Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer — Completed